![]() |
市場調查報告書
商品編碼
2026822
肺計量計市場預測至2034年-按產品、技術、應用、最終用戶和地區分類的全球分析Spirometers Market Forecasts to 2034 - Global Analysis By Product, By Technology, Application (Chronic Obstructive Pulmonary Disease, Asthma and Other Applications), End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球肺計量計市場規模將達到 16.71 億美元,在預測期內複合年成長率將達到 13.1%,到 2034 年將達到 44.845 億美元。
肺計量計是醫療設備。這些設備可以測量重要的呼吸參數,例如肺活量、氣流和呼吸肌肉效率。透過分析呼吸過程中空氣的體積和速度,肺計量計有助於評估肺功能,輔助診斷和監測氣喘、慢性阻塞性肺病(COPD)和其他呼吸系統疾病,並指導治療指南。
根據美國國家心肺血液研究所 2022 年 3 月發表的報導,慢性阻塞性肺病是美國的主要死因,影響約 1,600 萬美國人。
呼吸系統疾病發生率增加
隨著氣喘、慢性阻塞性肺病(COPD)和肺纖維化等呼吸系統疾病在全球的發生率不斷上升,對評估肺功能的診斷工具的需求也日益成長。肺計量計在這些疾病的診斷、後續觀察和治療效果評估中發揮著至關重要的作用。隨著呼吸系統疾病的早期發現和管理變得越來越重要,對肺活量計的需求持續成長,推動市場發展以滿足不斷成長的醫療需求。
認知度低且缺乏可用的使用環境
在某些地區和醫療機構,人們對呼吸系統健康評估的重要性以及肺功能測試的益處認知不足。此外,醫療設施的可近性差異限制了偏遠和醫療服務不足地區肺計量計的普及。醫護人員訓練不足也進一步阻礙了肺功能儀的推廣應用。這種認知不足和獲取途徑有限阻礙了肺功能儀的廣泛應用,限制了其使用,並影響了市場成長。
人們越來越傾向選擇居家醫療
居家醫療的日益普及為肺計量計市場帶來了機會。隨著患者尋求更便利的監測方式,攜帶式肺計量計透過在家中進行呼吸功能評估,滿足了這一趨勢。這些設備使慢性呼吸系統疾病患者能夠定期監測肺功能,從而及時進行干預並減少就醫次數。此外,居家照護的興起也契合了患者對獨立性和便利性的追求,推動了對攜帶式肺活量計解決方案的需求,並透過提供可在傳統醫療機構之外使用的呼吸監測方案,擴大了市場規模。
對資料隱私和安全的擔憂
當肺功能儀與用於資料儲存和分析的數位系統連接並整合時,潛在的資料外洩、未授權存取或資料濫用的風險會增加。肺功能檢查期間收集的患者健康資訊必須受到保護,以確保其保密。未能解決這些問題可能會損害患者的信任,阻礙技術的推廣應用,並招致監管機構的審查。
在新冠肺炎疫情期間,肺計量計面臨挑戰並需要調整。最初,人們擔心肺活量計檢查過程中會產生氣溶膠,感染風險影響了其使用。然而,隨著認知的加深,制定了相關規程以確保肺活量計檢查的安全,尤其是在重要的呼吸功能評估中。此外,疫情加速了遠端監測和遠端醫療解決方案的發展,促進了肺計量計融入虛擬醫療環境。這使得在最大限度減少面對面接觸的同時,能夠進行持續的呼吸監測和管理,從而提升遠距患者照護。
在預測期內,流量測量部分預計將達到最大規模。
在預測期內,由於流量測量在評估呼吸功能方面發揮著至關重要的作用,因此預計流量測量細分市場將推動肺計量計市場的發展。流量測量能夠提供吸氣和呼氣過程中氣流速度的關鍵數據,有助於呼吸系統疾病的診斷和監測。此外,流量測量的準確性和靈敏度顯著提高了呼吸功能的評估準確度,這也是該細分市場預計在肺計量計市場中佔據主導地位的主要因素。
在預測期內,醫院產業預計將呈現最高的複合年成長率。
在預測期內,醫院領域預計將顯著成長。醫院仍然是提供全面醫療保健服務的關鍵樞紐,包括呼吸系統疾病的診斷和治療。呼吸系統疾病盛行率的上升推動了醫院對先進肺功能儀的需求成長。此外,對呼吸系統疾病早期發現和管理的日益重視,進一步增加了醫院環境中對精準診斷工具的需求。同時,技術進步以及肺計量計與醫院資訊系統的整合,也進一步促進了該領域的成長。
由於北美擁有先進的醫療保健基礎設施、高額的醫療費用支出以及對呼吸系統健康的高度重視,預計北美將在肺計量計市場佔據最大的市場佔有率。此外,公眾意識的提高、有利的報銷政策以及肺活量計設備的科技進步也推動了市場成長。同時,北美呼吸系統疾病的高發生率及其在醫療保健創新方面的積極舉措,使該地區成為主要的市場領導,在肺活量計解決方案的採用和實施方面佔據了顯著佔有率。
由於呼吸系統疾病盛行率上升和人口老化,亞太地區的肺計量計市場預計將呈現強勁成長。此外,醫療保健支出增加、醫療基礎設施改善以及呼吸系統健康意識的提高也進一步推動了市場發展。同時,技術進步、攜帶式且價格適中的肺計量計計的普及以及農村地區醫療保健服務的拓展,都在加速亞太地區肺活量計市場的成長。
According to Stratistics MRC, the Global Spirometers Market is accounted for $1,671.0 million in 2026 and is expected to reach $4,484.5 million by 2034 growing at a CAGR of 13.1% during the forecast period. Spirometers are medical devices used to measure lung function by assessing the volume of air inhaled or exhaled. These instruments gauge vital respiratory parameters, including lung capacity, airflow and the efficiency of respiratory muscles. By analyzing the volume and speed of air movement during breathing maneuvers, spirometers aid in diagnosing and monitoring conditions like asthma, chronic obstructive pulmonary disease (COPD) and other respiratory disorders, guiding treatment and evaluating pulmonary function.
According to an article published by the National Heart, Lung, and Blood Institute in March 2022, COPD is the leading cause of death in the U.S., affecting about 16 million Americans.
Rising incidence of respiratory diseases
Owing to the increasing prevalence of respiratory diseases like asthma, COPD, and pulmonary fibrosis worldwide, there's a heightened demand for diagnostic tools to assess lung function. Spirometers play a pivotal role in diagnosing these ailments, monitoring disease progression, and evaluating treatment efficacy. With a rising emphasis on early detection and management of respiratory disorders, the demand for spirometry devices continues to grow, driving market expansion to cater to the escalating healthcare needs.
Lack of awareness and availability
In certain regions or healthcare settings, there's inadequate awareness regarding the importance of respiratory health assessment and the benefits of spirometry testing. Additionally, disparities in access to healthcare facilities restrict the availability of spirometers in remote or underserved areas. Insufficient training among healthcare professionals further impedes adoption. This lack of awareness and limited accessibility hinders widespread adoption of spirometry tools, constraining their usage and impacting market growth.
Growing preference for home healthcare
The increasing inclination towards home healthcare presents an opportunity in the spirometers market. As patients seek convenient monitoring options, portable spirometers cater to this trend by enabling respiratory assessments in home settings. These devices allow individuals with chronic respiratory conditions to regularly monitor lung function, facilitating timely intervention and reducing hospital visits. Moreover, the shift towards home-based care aligns with patient preferences for independence and convenience, driving the demand for portable spirometry solutions and expanding the market by offering accessible respiratory monitoring options outside traditional healthcare facilities.
Data privacy and security concerns
When spirometry devices are connected and integrated with digital systems for data storage and analysis, there's a heightened risk of potential breaches, unauthorized access or data misuse. Patient health information collected during spirometry tests requires protection to ensure confidentiality. Failure to address these concerns can erode patient trust, hinder adoption, and lead to regulatory scrutiny.
During the COVID-19 pandemic, spirometers faced challenges and adaptations. Initially, concerns arose regarding aerosol generation during spirometry tests, impacting their use due to infection risks. However, as understanding evolved, protocols were established to ensure safe spirometry practices, especially for essential respiratory assessments. Additionally, the pandemic accelerated the development of remote monitoring and telemedicine solutions, fostering the integration of spirometers into virtual healthcare setups, allowing continued respiratory monitoring and management while minimizing in-person contact and enhancing remote patient care.
The flow measurement segment is expected to be the largest during the forecast period
Over the forecast period, the flow measurement segment is anticipated to dominate the spirometers market, attributed to its fundamental role in assessing respiratory function. Flow measurements provide crucial data on the rate of air movement during inhalation and exhalation, aiding in the diagnosis and monitoring of respiratory conditions. Moreover, the precision and sensitivity of flow measurements contribute significantly to accurate respiratory assessments, making them a key driver for the segment's anticipated dominance in the spirometers market.
The hospitals segment is expected to have the highest CAGR during the forecast period
During the forecast period, the hospitals segment is poised to witness significant growth. Hospitals remain the primary centers for comprehensive healthcare services, including respiratory diagnostics and treatment. With a rising incidence of respiratory ailments, hospitals demand for advanced spirometry equipment is escalating. Additionally, the increasing focus on early detection and management of respiratory diseases augments the need for accurate diagnostic tools in hospital settings. Moreover, technological advancements and the integration of spirometers into hospital information systems further drive the growth of this segment.
North America is set to secure the largest market share in the spirometers market owing to its advanced healthcare infrastructure, high healthcare expenditure and robust focus on respiratory health. Additionally, increased awareness, favorable reimbursement policies and technological advancements in spirometry devices contribute to the market's growth. Furthermore, a high prevalence of respiratory diseases and a proactive approach to healthcare innovation in North America position the region as a key market leader, with a significant share in the adoption and implementation of spirometry solutions.
Asia Pacific is poised to register robust growth in the spirometers market owing to the region's rising prevalence of respiratory disorders coupled with a growing geriatric population. Additionally, increasing healthcare expenditure, improving healthcare infrastructure and a surge in awareness regarding respiratory health further drive the market. Moreover, technological advancements, the adoption of portable and affordable spirometry devices and the expansion of healthcare access to rural areas foster the market's growth in the Asia Pacific region.
Key players in the market
Some of the key players in spirometers market include Benson Medical Instruments, Bionet America, Inc., CareFusion, Cosmed Srl, Fukuda Sangyo Co., Ltd., Future Med Devices Pvt. Ltd., Medikro Oy, MGC Diagnostics Corporation, Midmark Corporation, Morgan Scientific Inc., NDD Medical Technologies, Nihon Kohden Corporation, Schiller AG, SDI Diagnostics, Vitalograph Ltd and Welch Allyn, Inc.
In September 2023, Alveofit (Roundworks Technologies) has received approval from the US Food and Drug Administration (FDA) for its portable digital spirometer, alveoair. With this approval, the company plans to start distributing the product in the US.
In January 2023, Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of a clinical study comparing the treatment effect between at-home mobile spirometry using digital biomarkers and in-clinic spirometry in patients with moderate asthma on long-acting beta-agonist (LABA) treatment.
In September 2022, RxCap, Inc. collaborated with ZEPHYRx to connect the ZEPHYRx online spirometry platform to RxCap's remote surveillance platform. RxCap's corporate customers, who include providers and payers, may now track the lung health of their clients and patients who have severe respiratory diseases.